Cardiac failure
Not yet recruitingEfficacy and Safety of Fixed‑Dose Combination of Dapagliflozin, Bisoprolol Fumarate, and Eplerenone vs Usual Care in Hospitalized Acute Heart Failure Patients
Efficacy and Safety of Fixed‑Dose Combination of Dapagliflozin, Bisoprolol Fumarate, and Eplerenone vs Usual Care in Hospitalized Acute Heart Failure Patients
- Disease:Cardiac failure
- Substances:Bisoprolol FumarateDapagliflozin+1
Spain- Participants:18–64 years · 65+ years
- Substances:Bisoprolol Fumarate
- Sponsor:Institut De Recherches Internationales Servier IRIS











